bionetide
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Mar 15, 2024 (NCT06849973)
Timeline
Indications
Studied for
Mechanism of action
IGF1R agonist
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06840496 | Phase 3 | Oct 30, 2025 | Biomed Industries, Inc. |
| NCT06849973 | Phase 2/Phase 3 (Phase 3) | Mar 15, 2024 | Biomed Industries, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomed Industries, Inc. | For profit | 2 | 2 | 1 | 2024 |
1 organizations
Page 1 / 1